Symposium:
105. Advances in RSV Prevention
Friday, October 5, 2018: 8:45 AM-10:00 AM
Room: N 24

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe advances in RSV molecular virology
  • describe advances in applications of RSV vaccines
  • understand approaches to RSV immunoprophylaxis

Target Audience: Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Pharmacists, Scientists, Vaccinologists

Tracks: Pediatric ID, Trainee, Adult ID


Moderators:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases and Susan I. Gerber, MD, Centers for Disease Control and Prevention

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-221-L01-P

Disclosures:

I. Damon, None

S. I. Gerber, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.